Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Senate FDA reform hearings scheduled for Feb. 21-22 in Labor & Human Resources Cmte..

This article was originally published in The Tan Sheet

Executive Summary

SENATE FDA REFORM HEARINGS SCHEDULED FOR FEB. 21-22 in the Labor & Human Resources Committee as the panel prepares for a mid-March mark-up of Sen. Nancy Kassebaum's (R-Kan.) FDA reform bill (S 1477). Hearings will focus on the agency's review process. FDA reform hopes appear to hinge on the moderate Kassebaum bill, which is best situated to pass in a shortened election-year session.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts